Tag: Value in Health Regional Issues

ISPOR’s VALUE IN HEALTH REGIONAL ISSUES ACCEPTED FOR INDEXING IN MEDLINE®/PUBMED®

Princeton, NJ—December 6, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced that its regional health economics and outcomes research (HEOR) publication, Value in Health Regional Issues, was recently accepted for indexing in MEDLINE®/PubMed®.

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Regional Issues Tagged with: , ,

ISPOR RECOGNIZES 2015 AWARDS PROGRAM RECIPIENTS AT 18th ANNUAL EUROPEAN CONGRESS

AWARDS RECOGNIZE EXCELLENCE AND OUTSTANDING TECHNICAL ACHIEVEMENT IN PHARMACOECONOMICS AND OUTCOMES RESEARCH  Milan, Italy—November 11, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized its 2015 ISPOR Award recipients at the 18th Annual European Congress in Milan, Italy. The

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

ASSURE SAFETY IN INTRAVENOUS MEDICATION USE IN CHINA

Beijing, China – Chinese inpatients have experienced overuse of intravenous medications, with a total of 10.4 billion infusion bottles for 1.3 billion Chinese people annually, approximately 8 infusion bottles per capita in 2009. However, few studies have yet been published

Posted in Comparative Effectiveness Research / Health Technology Assessment, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , ,

IS NEWLY INVENTED THROMBIN-RECEPTOR ANTAGONIST (TRA) EFFECTIVE AND SAFE ENOUGH TO COMBAT WITH HEART DISEASE?

Callaghan, NSW, Australia – Acute Coronary Syndrome (ACS) and Coronary Heart Disease (CHD) are important contributors to the increased morbidity and mortality rates worldwide. Currently, pharmacotherapy is the main treatment modality for patients with a history of ACS or CHD.

Posted in ISPOR News & Press, Outcomes Assessment, Value in Health Regional Issues Tagged with: , ,